A Paradigm Shift to Prevent HIV Drug Resistance

1. World Health Organization

2007

Management of HIV Infection and Antiretroviral Therapy in Adults and Adolescents. A Clinical Manual.

Available: http://www.searo.who.int/LinkFiles/Publications_Management_HIV_infection_antiretroviral_therapy_adults_adolescents.pdf. Accessed 8 April 2008

2. CalmyAFordNHirschelBReynoldsSJLynenL

2007

HIV viral load monitoring in resource-limited regions: Optional or necessary.

Clin Infect Dis

44

128

134

3. BissonGPGrossRBellamySChittamsJHislopM

2008

Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.

PLoS Med

5

e109

doi:10.1371/journal.pmed.0050109

4. MannheimerSFriedlandGMattsJChildCChesneyM

2002

The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials.

Clin Infect Dis

34

1115

1121

5. LiuHMillerLGHaysRDGolinCEWuT

2006

Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors.

J Acquir Immune Defic Syndr

41

315

322

6. ParrutiGManzoliLToroPMD'AmicoGRotoloS

2006

Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: predictors and impact on virologic response and relapse.

AIDS Patient Care STDS

20

48

56

7. BangsbergDR

2008

Preventing HIV antiretroviral resistance through better monitoring of treatment adherence.

J Infect Dis

197

S272

S278

8. GrossRYipBLo ReV3rdWoodEAlexanderCS

2006

A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression.

J Infect Dis

194

1108

1114

9. WoodEHoggRSYipBHarriganPRO'ShaughnessyMV

2003

Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L.

Ann Intern Med

139

810

816

10. HarriganRDongWAlexanderCYipBTingL

2003

The association between drug resistance and adherence determined by two independent methods in a large cohort of drug naive individuals starting triple therapy [abstract LB12].

Second International Conference on HIV Treatment and Pathogenesis; 13–17 July 2003; Paris, France

11. HoggRHeathKBangsbergDRYipBPressN

2002

Intermittent use of triple combination therapy is predictive of mortality at baseline and after one year of follow-up AIDS.

AIDS

16

1051

1058

12. ParientiJMassariVDescampsDVabretABouvetE

2004

Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine or efavirenz-based antiretroviral therapy.

Clin Infect Dis

38

1311

1316

13. OyugiJHByakika-TusiimeJRaglandKLaeyendeckerOMugerwaR

2007

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.

AIDS

21

965

971

14. RuskinPVan der WendeJClarkCFentonJDeveauJ

2003

Feasibility of using the Med-eMonitor system in the treatment of schizophrenia: A pilot study.

Drug Inf J

37

283

291

15. YbarraMLBullSS

2007

Current trends in Internet- and cell phone-based HIV prevention and intervention programs.

Curr HIV/AIDS Rep

4

201

207

16. PhillipsANPillayDMinersAHBennettDEGilksCF

2008

Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: A computer simulation model.

Lancet

371

1443

1451